1. Home
  2. LADR vs CGON Comparison

LADR vs CGON Comparison

Compare LADR & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LADR
  • CGON
  • Stock Information
  • Founded
  • LADR 2008
  • CGON 2010
  • Country
  • LADR United States
  • CGON United States
  • Employees
  • LADR N/A
  • CGON N/A
  • Industry
  • LADR Real Estate Investment Trusts
  • CGON
  • Sector
  • LADR Real Estate
  • CGON
  • Exchange
  • LADR Nasdaq
  • CGON NYSE
  • Market Cap
  • LADR 1.5B
  • CGON 1.3B
  • IPO Year
  • LADR 2014
  • CGON 2024
  • Fundamental
  • Price
  • LADR $10.25
  • CGON $20.64
  • Analyst Decision
  • LADR Buy
  • CGON Strong Buy
  • Analyst Count
  • LADR 6
  • CGON 10
  • Target Price
  • LADR $13.17
  • CGON $65.11
  • AVG Volume (30 Days)
  • LADR 797.7K
  • CGON 1.3M
  • Earning Date
  • LADR 04-24-2025
  • CGON 05-08-2025
  • Dividend Yield
  • LADR 8.99%
  • CGON N/A
  • EPS Growth
  • LADR 6.17
  • CGON N/A
  • EPS
  • LADR 0.86
  • CGON N/A
  • Revenue
  • LADR $271,184,000.00
  • CGON $1,139,000.00
  • Revenue This Year
  • LADR $9.11
  • CGON N/A
  • Revenue Next Year
  • LADR $8.48
  • CGON $16,237.24
  • P/E Ratio
  • LADR $11.92
  • CGON N/A
  • Revenue Growth
  • LADR 6.98
  • CGON 461.08
  • 52 Week Low
  • LADR $9.68
  • CGON $14.80
  • 52 Week High
  • LADR $12.48
  • CGON $46.99
  • Technical
  • Relative Strength Index (RSI)
  • LADR 37.28
  • CGON 43.38
  • Support Level
  • LADR $10.01
  • CGON $19.47
  • Resistance Level
  • LADR $10.34
  • CGON $20.63
  • Average True Range (ATR)
  • LADR 0.41
  • CGON 2.07
  • MACD
  • LADR -0.06
  • CGON 0.20
  • Stochastic Oscillator
  • LADR 30.65
  • CGON 48.59

About LADR Ladder Capital Corp

Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: